BW-755-C

N/A

Report date: 2025/03/18 17:32:18

NME

Base Information

Drug NameBW-755-C

Drug Alias NameBW-755-C

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCyclooxygenases inhibitors5-lipoxygenase activating protein inhibitors

Targets5-lipoxygenase activating proteinCyclooxygenases

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGlaxosmithkline Plc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A